FDA Adverse Event Injury Summary report: N

REMISOL ADVANCE (RADV)

MDR report key: 9617299 · Received January 22, 2020

Report

Report Number
3006543086-2020-00001
Event Type
Injury
Date Received
January 22, 2020
Date of Event
January 3, 2020
Report Date
January 22, 2020
Manufacturer
NORMAND-INFO S.A.S.U.
Product Code
JQP
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BECKMAN COULTER CUSTOMER TECHNICAL SERVICE (CTS) EVALUATED THE EVENT, AND IDENTIFIED THE "VALIDATION RANGE" SETTINGS WERE INCORRECT. THE PATIENT WAS ONE (1) DAY OLD AND WAS NOT INCLUDED IN THE "LESS THAT 1 DAY OLD" VALIDATION RANGE. CTS CONFIRMED THAT THE RULES RAN AS EXPECTED BASED ON THE "VALIDATION RANGE" SETTINGS. THE SETTINGS WERE ADJUSTED TO RESOLVE THE ISSUE. AGE OR DATE OF BIRTH, WEIGHT, AND ETHNICITY: INFORMATION NOT PROVIDED BY CUSTOMER. (B)(6). THE BECKMAN COULTER INTERNAL IDENTIFIER IS (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED CRITICAL TBIL (TOTAL BILIRUBIN) RESULTS FOR AN INFANT WERE AUTO VALIDATED BY REMISOL ADVANCE (RADV) WHEN IT SHOULD HAVE NOT BEEN AUTO VALIDATED, WHICH CAUSED A DELAY IN PATIENT TREATMENT BY ONE (1) DAY. THERE WAS NO REPORT OF INJURY OR DEATH ASSOCIATED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
79998 REMISOL ADVANCE (RADV) CALCULATOR/DATA PROCESSING MODULE, FOR CLINICAL USE JQP NORMAND-INFO S.A.S.U. WORK STATION, US HW, RADV NA

Patients

Seq Age Sex Outcome Treatment
1 1 DA Other